Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Amir Kaki, MD
Ascension St. John Hospital
Principal Investigator - Seth Bilazarian, MD
Abiomed Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Joseph'S Medical Center - Phoenix
Phoenix, Arizona, United States
- Pima Heart & Vascular
Tucson, Arizona, United States
- Arkansas Heart Hospital
Little Rock, Arkansas, United States
- Adventist Health Glendale
Glendale, California, United States
- Keck Hospital of Usc
Los Angeles, California, United States
- Loma Linda University Medical Center
San Bernardino, California, United States
- Manatee Memorial Hospital
Bradenton, Florida, United States
- North Florida Regional Medical Center
Gainesville, Florida, United States
- Adventhealth - Tampa
Tampa, Florida, United States
- Emory University Hospital
Atlanta, Georgia, United States
- Ochsner Foundation Hospital
New Orleans, Louisiana, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- Ascension St. John Hospital
Detroit, Michigan, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Spectrum Health
Grand Rapids, Michigan, United States
- St. Cloud (centracare)
Saint Cloud, Minnesota, United States
- Providence St. Patrick
Missoula, Montana, United States
- Hackensack University Medical Ctr
Hackensack, New Jersey, United States
- Morristown Medical Center
Morristown, New Jersey, United States
- the Valley Hospital
Ridgewood, New Jersey, United States
- New Mexico Heart Institute
Albuquerque, New Mexico, United States
- Buffalo General
Buffalo, New York, United States
- Cumc/ New York Presbyterian Hospital
New York, New York, United States
- Lenox Hill Hospital
New York, New York, United States
- Oklahoma Heart Hospital - South
Oklahoma City, Oklahoma, United States
- Providence St. Vincent Med Center
Portland, Oregon, United States
- Tristar Centennial Medical Center
Nashville, Tennessee, United States
- Texas Health Presbyterian Hospital Dallas
Dallas, Texas, United States
- Baylor Scott & White the Heart Hospital Plano
Plano, Texas, United States
- Methodist Hospital - San Antonio
San Antonio, Texas, United States
- Sentara Norfolk Health System
Norfolk, Virginia, United States
- West Virginia University Hospital
Morgantown, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Dec 2022
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 5 Mar 2026
- Registered enrollment
- 856
- Registry id
- NCT05334784
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.